N
Nicola Zanesi
Researcher at Ohio State University
Publications - 83
Citations - 8521
Nicola Zanesi is an academic researcher from Ohio State University. The author has contributed to research in topics: FHIT & Cancer. The author has an hindex of 35, co-authored 83 publications receiving 7925 citations. Previous affiliations of Nicola Zanesi include Thomas Jefferson University & University of Padua.
Papers
More filters
Journal ArticleDOI
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.
Alessandra Drusco,Arianna Bottoni,Alessandro Laganà,Mario Acunzo,Matteo Fassan,Luciano Cascione,Anna Antenucci,Prasanthi Kumchala,Caterina Vicentini,Marina Paola Gardiman,Hansjuerg Alder,Mariantonia Carosi,Mario Ammirati,Stefano Gherardi,Marilena Luscrì,Carmine M. Carapella,Nicola Zanesi,Carlo M. Croce +17 more
TL;DR: It is demonstrated that Cerebro-Spinal Fluid microRNA profiling mirrors Central Nervous System physiologic or pathologic conditions and has good perspectives for future diagnostic clinical applications.
Journal ArticleDOI
Pluripotent Stem Cell miRNAs and Metastasis in Invasive Breast Cancer
Stefano Volinia,Gerard J. Nuovo,Alessandra Drusco,Stefan Costinean,Ramzey Abujarour,Caroline Desponts,Michela Garofalo,Raffaele Baffa,Rami Aeqilan,Kati Maharry,Maria Elena Sana Ramiro Garzon,Gianpiero Di Leva,Pierluigi Gasparini,Paola Dama,Jlenia Marchesini,Marco Galasso,Marco Manfrini,Carlotta Zerbinati,Fabio Corrà,Timothy F. Wise,Sylwia E. Wojcik,Maurizio Previati,Flavia Pichiorri,Nicola Zanesi,Hansjuerg Alder,Jeff Palatini,Kay Huebner,Charles L. Shapiro,Massimo Negrini,Andrea Vecchione,Anne L. Rosenberg,Carlo M. Croce +31 more
TL;DR: In invasive ductal carcinoma, the MIR302/MIR203 asymmetry was associated with stem cell markers, metastasis, and shorter survival, and overall survival was statistically significantly shorter in patients with MIR 302-positive cancer cells.
Journal ArticleDOI
Effect of Rapamycin on Mouse Chronic Lymphocytic Leukemia and the Development of Nonhematopoietic Malignancies in Eμ-TCL1 Transgenic Mice
Nicola Zanesi,Rami I. Aqeilan,Alessandra Drusco,Mohamed Kaou,Cinzia Sevignani,Stefan Costinean,Laura Bortesi,Laura Bortesi,Gaspare La Rocca,Pavel Koldovsky,Stefano Volinia,Rita Mancini,Rita Mancini,George A. Calin,Charles P. Scott,Yuri Pekarsky,Carlo M. Croce +16 more
TL;DR: Findings indicate that other oncogenic mechanism(s) may be involved in the development of solid tumors in Emu-TCL1 transgenic mice by testing the ability of a specific pharmacologic agent, rapamycin, to slow CLL.
Journal ArticleDOI
Fhit is a physiological target of the protein kinase Src.
Yuri Pekarsky,P.N. Garrison,Alexey Palamarchuk,Nicola Zanesi,Rami I. Aqeilan,Kay Huebner,Larry D. Barnes,Carlo M. Croce +7 more
TL;DR: It is demonstrated that Fhit is a target of tyrosine phosphorylation by the Src protein kinase in vitro and in vivo, providing insight into a biochemical pathway involved in Fhit signaling.
Journal ArticleDOI
Animal models for chronic lymphocytic leukemia.
TL;DR: What has been learned from mice with B‐CLL phenotype is presented and how these mouse models of B-CLL were used to test therapeutic treatments for this common leukemia are presented.